These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22569017)

  • 1. Comments on a prospective study into using prokinetics with proton pump inhibitors.
    Langstaff L
    J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):152. PubMed ID: 22569017
    [No Abstract]   [Full Text] [Related]  

  • 2. Virtue of adding prokinetics to proton pump inhibitors in the treatment of laryngopharyngeal reflux disease: prospective study.
    Ezzat WF; Fawaz SA; Fathey H; El Demerdash A
    J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):350-6. PubMed ID: 21777555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency scale symptoms for gastroesophageal reflux disease (Frequency Scale for Symptoms of GERD) predicts need for addition of prokinetics to proton pump inhibitor therapy.
    Nandurkar S
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1165-7. PubMed ID: 18699977
    [No Abstract]   [Full Text] [Related]  

  • 4. Which PPI?
    Med Lett Drugs Ther; 2015 Jun; 57(1471):91. PubMed ID: 26079763
    [No Abstract]   [Full Text] [Related]  

  • 5. Limited efficacy of antigastroesophageal reflux medications in children.
    Berman J
    J Pediatr; 2015 May; 166(5):1321-2. PubMed ID: 25919740
    [No Abstract]   [Full Text] [Related]  

  • 6. PHARMACOLOGICAL TREATMENT OF CHILDREN WITH GASTRO-ESOPHAGEAL REFLUX: A SUMMARY.
    Gaines C
    Gastroenterol Nurs; 2016; 39(1):68-70. PubMed ID: 26825568
    [No Abstract]   [Full Text] [Related]  

  • 7. Addition of prokinetic therapy to a PPI in reflux diseases.
    Hsu YC; Lin HJ
    Aliment Pharmacol Ther; 2011 Apr; 33(8):983-4; author reply 984-5. PubMed ID: 21434953
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
    Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
    J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflux and Chronic Rhinosinusitis.
    Bock JM; Poetker DM
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):633-4. PubMed ID: 27280868
    [No Abstract]   [Full Text] [Related]  

  • 10. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996.
    Heading RC; Baldi F; Holloway RH; Janssens J; Jian R; McCallum RW; Richter JE; Scarpignato C; Sontag SJ; Wienbeck M
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):87-93. PubMed ID: 9512959
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
    Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatments of GERD: the old and new.
    Vela MF
    Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
    Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
    Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of medication after laparoscopic anti-reflux surgery.
    Hussain A; Singhal T; Almusawy H; El-Hasani S
    Surg Endosc; 2010 Sep; 24(9):2358. PubMed ID: 20186435
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological management of GERD: where does it stand now?
    Hershcovici T; Fass R
    Trends Pharmacol Sci; 2011 Apr; 32(4):258-64. PubMed ID: 21429600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gastroesophageal reflux disease in primary care settings in Spain: SYMPATHY I study.
    Ferrús JA; Zapardiel J; Sobreviela E;
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1269-78. PubMed ID: 19474743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimal diagnosis and therapy of gastroesophageal reflux disease].
    Ivanikov AA; Isakov VA; Maev IV
    Ter Arkh; 2004; 76(2):71-5. PubMed ID: 15106421
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
    Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
    Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.